Target intelligence / Profile preview

Family with sequence similarity 224 member A (FAM224A)

Target
FAM224A
Molecular classification
Other (long non-coding RNA; lncRNA)
01

Overview

Family with sequence similarity 224 member A (FAM224A) is a long non-coding RNA (lncRNA) that is upregulated in glioma tissues and cell lines, where it promotes malignant progression by supporting cell proliferation, migration, and invasion, while inhibiting apoptosis[1]. Functionally, it acts as a molecular sponge for miR-590-3p and is involved in a positive feedback regulatory network with transcription factor ZNF143 and RNA-binding protein A1CF, contributing to carcinogenesis. High FAM224A expression is associated with advanced glioma pathology and poor prognosis, making it a potential biomarker and a target of therapeutic interest in glioma[1].

Other names
FAM224A
02

Mechanism of action

Not applicable (as no drugs are directly known to target FAM224A). Acts as a competitive endogenous RNA (molecular sponge) for miR-590-3p, modulating expression of transcription factors such as ZNF143.

03

Biological functions

Regulation of gene expression (acts as a molecular sponge for miR-590-3p, involved in RNA-induced silencing complex)Modulation of cell proliferation, migration, invasion, and apoptosisPositive feedback loop with ZNF143, influencing transcription of itself and other genes
04

Disease associations

Cancer (specifically glioma, where it acts as an oncogene)
05

Biomarkers

High FAM224A expression is a negative prognostic marker for glioma (associated with advanced grade and poorer prognosis)

Beyond the preview

Go deeper on Family with sequence similarity 224 member A (FAM224A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Family with sequence similarity 224 member A (FAM224A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call